These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7807685)

  • 1. Intraventricular changes in the beta-adrenoceptor-adenylate cyclase system of the rat heart with the progress of monocrotaline-induced right ventricular hypertrophy.
    Yoshie H; Tobise K; Onodera S
    Jpn Circ J; 1994 Nov; 58(11):855-65. PubMed ID: 7807685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.
    Fan TH; Liang CS; Kawashima S; Banerjee SP
    Eur J Pharmacol; 1987 Aug; 140(2):123-32. PubMed ID: 2822436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential changes in left and right ventricular adenylyl cyclase activities in congestive heart failure.
    Sethi R; Dhalla KS; Beamish RE; Dhalla NS
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H884-93. PubMed ID: 9124452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-adrenergic receptor/adenylate cyclase system in the cardiac ventricles of a hypertrophic cardiomyopathy rat model.
    Yamamoto S; Katsume H; Nakagawa M; Kuribayashi T; Hashimoto T; Kuriyama K
    Jpn Circ J; 1992 Apr; 56(4):376-83. PubMed ID: 1315878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats.
    Seyfarth T; Gerbershagen HP; Giessler C; Leineweber K; Heinroth-Hoffmann I; Pönicke K; Brodde OE
    J Mol Cell Cardiol; 2000 Dec; 32(12):2315-26. PubMed ID: 11113007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion.
    León-Velarde F; Bourin MC; Germack R; Mohammadi K; Crozatier B; Richalet JP
    Am J Physiol Regul Integr Comp Physiol; 2001 Jan; 280(1):R274-81. PubMed ID: 11124161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta adrenoceptor density and adenylate cyclase response in right atrial and left ventricular myocardium of patients with mitral valve disease.
    Golf S; Andersen D; Hansson V
    Cardiovasc Res; 1986 May; 20(5):331-6. PubMed ID: 3019547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenoceptors and adenylate cyclase activity in hypertrophied and failing rabbit left ventricle.
    Bouanani N; Corsin A; Gilson N; Crozatier B
    J Mol Cell Cardiol; 1991 May; 23(5):573-81. PubMed ID: 1679457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of right and left ventricular beta-adrenergic receptors in newborn lambs with experimental cyanotic heart disease.
    Bernstein D; Voss E; Huang S; Doshi R; Crane C
    J Clin Invest; 1990 Jan; 85(1):68-74. PubMed ID: 2153153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat.
    Zhang TT; Cui B; Dai DZ
    Acta Pharmacol Sin; 2004 Feb; 25(2):226-30. PubMed ID: 14769214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals.
    Persad S; Takeda S; Panagia V; Dhalla NS
    J Mol Cell Cardiol; 1997 Feb; 29(2):545-58. PubMed ID: 9140814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The adrenergic beta system in an experimental model of heart failure].
    Pelà G; Raddino R; Missale C; Condorelli E; Spano PF; Visioli O
    Cardiologia; 1990 Jul; 35(7):543-50. PubMed ID: 1965156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between beta-adrenoceptor occupancy and increases of contractile force and adenylate cyclase activity induced by catecholamines in human ventricular myocardium. Acute desensitization and comparison with feline ventricle.
    Kaumann AJ; Lemoine H; Schwederski-Menke U; Ehle B
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):99-112. PubMed ID: 2542808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor adenylate cyclase system adaptation to physical training in rat ventricular tissue.
    Plourde G; Rousseau-Migneron S; Nadeau A
    J Appl Physiol (1985); 1991 Apr; 70(4):1633-8. PubMed ID: 1647390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac and vascular responses after monocrotaline-induced hypertrophy in rats.
    Brown L; Miller J; Dagger A; Sernia C
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):108-15. PubMed ID: 9456285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid status affects the rat cardiac beta-adrenoceptor system transiently and time-dependently.
    Zwaveling J; Batink HD; Taguchi K; de Jong J; Michel MC; Pfaffendorf M; van Zwieten A
    J Auton Pharmacol; 1998 Feb; 18(1):1-11. PubMed ID: 9728320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac adenylate cyclase. II. Structure-activity relationships for the activation of rat ventricle adenylate cyclase by beta-adrenoceptor agonists.
    Picken GM; Jarrott B
    Biochem Pharmacol; 1975 Dec; 24(24):2255-61. PubMed ID: 3180
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac beta-adrenoceptor changes in monocrotaline-treated rats: differences between membrane preparations from whole ventricles and isolated ventricular cardiomyocytes.
    Leineweber K; Seyfarth T; Abraham G; Gerbershagen HP; Heinroth-Hoffmann I; Pönicke K; Brodde OE
    J Cardiovasc Pharmacol; 2003 Mar; 41(3):333-42. PubMed ID: 12605011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure.
    Leineweber K; Brandt K; Wludyka B; Beilfuss A; Pönicke K; Heinroth-Hoffmann I; Brodde OE
    Circ Res; 2002 Nov; 91(11):1056-62. PubMed ID: 12456492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.